Skip to content

Study on Treating by Eating: Role of AGEs on Mucosal Barrier and Microbiome.

Study on Treating by Eating: Role of AGEs on Mucosal Barrier and Microbiome.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06547190
Acronym
STEAMM
Enrollment
20
Registered
2024-08-09
Start date
2022-02-01
Completion date
2022-07-30
Last updated
2024-08-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

Advanced Glycation End products, Cooking Methods, Culinary Techniques

Brief summary

This is an exploratory study aimed at healthy volunteers to investigate the impact of differential cooking methods on global and gut inflammation, intestinal permeability, and the gut microbiota. The investigators hypothesize that a short dietary intervention of baking and grilling of food for 2 weeks as opposed to steaming and boiling of food for 2 weeks will result in measurable differences in blood, stool and urine samples that guide towards gut and overall health and disease. All food will be provided, together with detailed cooking instructions. Food logs including photographs will be used to check whether participants complied with the study. The investigators aim to better understand the role of cooking methods in human health, so that this can be implemented in preventive strategies and dietary treatments for specific patient groups.

Detailed description

This is a pilot project aimed at healthy volunteers to investigate the impact of differential cooking methods on systemic and intestinal inflammation, permeability, and the gut microbiota, using a randomised cross-over design. The investigators hypothesize that a short dietary intervention of baking and grilling of food for 2 weeks (high-Advanced Glycation End Products (AGEs) diet) as opposed to steaming and boiling of food for 2 weeks (low-AGEs diet) will result in measurable differences in inflammatory, cardiometabolic and microbial markers in blood and stool as well as changes in intestinal permeability through their effect on dietary AGEs. All food will be provided, together with detailed cooking instructions. Food logs including photographs will be used to assess and check adherence to the intervention. The investigators aim to better understand the role of cooking methods and thermal treatments in human health, so that this can be implemented in preventive strategies and dietary treatments for specific patient groups.

Interventions

BEHAVIORALHigh AGEs diet

Participants sequentially consumed a diet that was high in AGEs and low in AGEs just be altering their cooking method. The High AGEs diet was cooked for example by baking and grilling.

BEHAVIORALLow AGEs diet

Participants sequentially consumed a diet that was high in AGEs and low in AGEs just be altering their cooking method. The low AGEs diet was cooked for example by steaming and boiling.

Sponsors

Vlaams Instituut voor Biotechnologie (VIB)
CollaboratorUNKNOWN
Universitaire Ziekenhuizen KU Leuven
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

Randomized Cross-over Trial

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Overall healthy * Adhering to an omnivorous diet * Body Mass Index (BMI) between 18.5 - 30 kg/m2 * Able to provide consent.

Exclusion criteria

* Participants with chronic illnesses including diabetes mellitus, cardiovascular disease, or cancer; eating disorders, irritable bowel syndrome; inflammatory bowel diseases, and previous bowel surgery (except for appendectomy). * Current smoking * Participants taking nonsteroidal anti-inflammatory drugs (NSAIDS), proton pump inhibitors, antacids, or laxatives one month before enrollment or antibiotics, prebiotics or probiotics six months before the start of the trial. * Pregnancy of lactation

Design outcomes

Primary

MeasureTime frameDescription
Intestinal inflammation2 weeksMeasurement of faecal calprotectin through stool samples (in mg/kg)
Gut microbial metabolism2 weeksMeasurement of short chain fatty acids including acetic acid, propionic acid and butyric acid through stool samples (in mg/100g stool)
Gut microbial composition2 weeksMeasurement of the composition of the gut microbiota using 16s rRNA sequencing of stool samples.
Intestinal transcellular permeability2 weeksMeasurement of transcellular intestinal permeability using lipopolysaccharide binding protein in blood samples
Intestinal paracellular permeability2 weeksMeasurement of paracellular intestinal permeability using the lacultulose mannitol test using urine samples
Systemic inflammation2 weeksserum inflammation through OLINK inflammatory panel (measurement of 92 proteins in blood)
Systemic cardiometabolic health2 weeksserum cardiometabolic parameters through OLINK cardiometabolic panel (measurement of 92 proteins in blood)
Systemic lipid profile2 weeksTotal, LDL- and HDL-cholesterol values in blood samples (in mg/dl)
Weight changes2 weeksweight (in kg)
Handgrip strength changes2 weeksHandgrip strength (in kg)

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 5, 2026